Adli A. Selim

490 total citations
29 papers, 379 citations indexed

About

Adli A. Selim is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Adli A. Selim has authored 29 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Organic Chemistry and 8 papers in Molecular Biology. Recurrent topics in Adli A. Selim's work include Radiopharmaceutical Chemistry and Applications (12 papers), Nanoparticle-Based Drug Delivery (6 papers) and Synthesis and Biological Evaluation (5 papers). Adli A. Selim is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Nanoparticle-Based Drug Delivery (6 papers) and Synthesis and Biological Evaluation (5 papers). Adli A. Selim collaborates with scholars based in Egypt, Saudi Arabia and Switzerland. Adli A. Selim's co-authors include M. A. Motaleb, M. H. Sanad, Maher A. El‐Hashash, Kurls E. Anwer, Tamer M. Sakr, Galal H. Sayed, Wafaa A. Zaghary, Mohammed A. Khedr, Reem I. Al-Wabli and Marwa H. Abdallah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Adli A. Selim

27 papers receiving 378 citations

Peers

Adli A. Selim
Dongjian Zhang China
Alice Lázníčková Czechia
Michele Iori Italy
Emilija Janevik-Ivanovska North Macedonia
Masahide Kobayashi Japan
Ibrahim Al‐Jammaz Saudi Arabia
Xiaowei Wu China
Sara Piccinonna Italy
María José Guillén Spain
Hongmei Wu China
Dongjian Zhang China
Adli A. Selim
Citations per year, relative to Adli A. Selim Adli A. Selim (= 1×) peers Dongjian Zhang

Countries citing papers authored by Adli A. Selim

Since Specialization
Citations

This map shows the geographic impact of Adli A. Selim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adli A. Selim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adli A. Selim more than expected).

Fields of papers citing papers by Adli A. Selim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adli A. Selim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adli A. Selim. The network helps show where Adli A. Selim may publish in the future.

Co-authorship network of co-authors of Adli A. Selim

This figure shows the co-authorship network connecting the top 25 collaborators of Adli A. Selim. A scholar is included among the top collaborators of Adli A. Selim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adli A. Selim. Adli A. Selim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selim, Adli A., et al.. (2025). Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study. Archiv der Pharmazie. 358(3). e2400725–e2400725. 1 indexed citations
2.
Selim, Adli A., et al.. (2025). 99mTc-labeled benzenesulfonamide derivative-entrapped gold citrate nanoparticles as an auspicious tumour targeting. Scientific Reports. 15(1). 4687–4687. 2 indexed citations
3.
4.
Rashed, Hassan M., et al.. (2024). Revitalizing Itraconazole: Unleashing its Anticancer Potential through Oral Nanosystems for Liver Targeting and Biodistribution Profiling in an Animal Model using Radiolabeling Technique. Journal of Drug Delivery Science and Technology. 104. 106463–106463. 12 indexed citations
5.
Hammam, Olfat, et al.. (2024). Novel pyridine bearing pentose moiety-based anticancer agents: design, synthesis, radioiodination and bioassessments. Scientific Reports. 14(1). 2738–2738. 13 indexed citations
6.
Selim, Adli A., et al.. (2024). Biogenic harmony of biocompatible silver nanoplatforms using chamomile extract and apigenin-7-glucoside for solid tumor therapy. Journal of Radioanalytical and Nuclear Chemistry. 333(2). 705–715. 2 indexed citations
7.
Selim, Adli A., et al.. (2024). Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the FirstNuclear Medicine Imaging Probe for ETRA Brain Receptor. Current Radiopharmaceuticals. 17(2). 209–217. 2 indexed citations
8.
Anwer, Kurls E., et al.. (2023). Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo/radioisotope therapy. BMC Chemistry. 17(1). 139–139. 10 indexed citations
9.
10.
Selim, Adli A., et al.. (2023). Gold Nanoparticles: Synthesis, Functionalization and Biomedical Applications Especially in Cardiovascular Therapy. Pharmaceutical Chemistry Journal. 57(1). 29–39. 5 indexed citations
11.
Selim, Adli A., et al.. (2023). Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique. Journal of Cancer Research and Clinical Oncology. 149(20). 18065–18080. 1 indexed citations
12.
Selim, Adli A., et al.. (2022). Conventional and microwave-assisted synthesis, anticancer evaluation, 99mTc-coupling and In-vivo study of some novel pyrazolone derivatives. Bioorganic Chemistry. 125. 105846–105846. 23 indexed citations
13.
Selim, Adli A., et al.. (2022). Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy. International Journal of Pharmaceutics. 628. 122345–122345. 12 indexed citations
14.
Selim, Adli A., et al.. (2022). Bone targeted new zoledronate derivative: design, synthesis, 99mTc-coupling, in-silico study and preclinical evaluation for promising osteosarcoma therapy. International Journal of Radiation Biology. 98(11). 1664–1672. 4 indexed citations
15.
Selim, Adli A., et al.. (2021). Extraction, purification and radioiodination of Khellin as cancer theranostic agent. Applied Radiation and Isotopes. 178. 109970–109970. 14 indexed citations
16.
Abdulwahab, Hanan Gaber, et al.. (2020). Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study. Bioorganic & Medicinal Chemistry. 28(23). 115759–115759. 31 indexed citations
17.
Selim, Adli A., et al.. (2019). Recombinant human insulin as a solid tumor potential imaging agent: Radio-synthesis and biological evaluation. SHILAP Revista de lepidopterología. 3(3). 341–350. 3 indexed citations
18.
Selim, Adli A., et al.. (2019). Synergistic Cytotoxicity Of Shikonin‐Silver Nanoparticles As An Opportunity For Lung Cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 63(1). 25–32. 34 indexed citations
19.
Motaleb, M. A. & Adli A. Selim. (2018). Dioximes: Synthesis and biomedical applications. Bioorganic Chemistry. 82. 145–155. 27 indexed citations
20.
Al-Wabli, Reem I., et al.. (2016). Platelet-12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium-99m. Chemistry Central Journal. 10(1). 73–73. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongjian Zhang Breakdown of academic impact, for papers by Alice Lázníčková Breakdown of academic impact, for papers by Michele Iori Breakdown of academic impact, for papers by Emilija Janevik-Ivanovska Breakdown of academic impact, for papers by Masahide Kobayashi Breakdown of academic impact, for papers by Ibrahim Al‐Jammaz Breakdown of academic impact, for papers by Xiaowei Wu Breakdown of academic impact, for papers by Sara Piccinonna Breakdown of academic impact, for papers by María José Guillén Breakdown of academic impact, for papers by Hongmei Wu
Rankless by CCL
2026